Illustration of a diverse group of people

Our focus

Our mission is to deliver impactful medicines and solutions for a healthier every day.

Our portfolio across women’s health and general medicines

We work to provide medicines to patients when and where they need them in over 140 markets, across a wide array of conditions and diseases.

Women’s health

We are committed to delivering innovation, improving access, and expanding choice to help address therapeutic gaps in women’s health.

Illustration of pregnant patient holding female doctor's hand

For far too long, the study of women’s health issues has been underfunded. Just 4% of all healthcare research and development is focused on women’s health, and women are still underrepresented in nearly all clinical trials.i

Organon’s portfolio and innovation pipeline are focused on these key areas:

  • bacterial vaginosis (BV)
  • breast cancer
  • contraception
  • fertility
  • hysterectomy
  • menopause
  • osteoporosis
  • polyendocrine metabolic ovarian syndrome (PMOS)

General medicines

We support patients in managing critical, chronic, and acute conditions – including those that affect women disproportionately or differently, such as atopic dermatitis, cardiovascular disease, and migraine.

Biosimilars

Our biosimilars portfolio plays a vital role in expanding access to essential treatments by offering potentially more affordable options for patients.

Learn more about Organon Biosimilars

Illustration of male doctor in scrubs and male patient

With insights from our customers, we work to understand the needs of all stakeholders and seek to exceed their expectations.

Helping navigate the complexities of biosimilar adoption is at the core of our commitment to enable the many potential benefits of biosimilars across the health care system. As the biosimilar landscape changes, we adapt—while maintaining an unwavering commitment to patients and providers.

We believe that ethics, empathy, and commitment will ultimately best serve all our stakeholders on the path toward value-driven change.

Established brands

Our portfolio includes many products that have been supporting patients across a range of diseases and conditions for decades. To help address unmet needs and reach those who need our products the most, we continuously work to expand access to these medicines through new indications, markets and populations. 

illustration of two women running. One woman has a prosthetic leg.

Our general medicines include well-known products across a range of therapeutic areas:

  • Dermatology
  • Neurology
  • Cardiovascular disease (CVD)
  • Autoimmune conditions
  • Bone health
  • Respiratory conditions

i. DeSilva J, Krasnainsky A. Building comprehensive women+ digital health: Eight sectors serving Women+ needs: Rock Health. https://rockhealth.com/insights/building-comprehensive-women-digital-health-eight-sectors-serving-women-needs/.